BUENA, N.J., Feb. 14, 2014 /PRNewswire/ -- IGI
Laboratories, Inc. (NYSE MKT: IG), a New
Jersey based topical generic drug development and
manufacturing company, announced the Company will hold a conference
call at 4:30 pm ET on Thursday, February 27, 2014 to discuss the 4th
quarter 2013 results.
(Logo:
http://photos.prnewswire.com/prnh/20130827/MM70487LOGO)
The Company invites you to listen to the call by dialing
1-866-515-2908. International participants should call
1-617-399-5122. The passcode for the conference call is
49729279.
This call is being webcast by Thomson and can be accessed at
IGI's website at www.igilabs.com.
The webcast is also being distributed through the Thomson
StreetEvents Network. Individual investors can listen to the call
at www.earnings.com, Thomson's individual investor portal, powered
by StreetEvents (www.streetevents.com), a password-protected event
management site.
About IGI Laboratories, Inc.
IGI Laboratories is a generic topical pharmaceutical
company. We develop and manufacture topical formulations for
the pharmaceutical, OTC, and cosmetic markets. Our mission is to be
a leading player in the generic topical prescription drug
market.
SOURCE IGI Laboratories, Inc.